Haploidentical, Related, Unrelated: Does Donor Type Impact HTC Outcomes?
Matched sibling donors aside, donor type was not associated with significant differences in overall survival in patients with myelofibrosis who underwent HCT.
Read MoreSep 9, 2024
Matched sibling donors aside, donor type was not associated with significant differences in overall survival in patients with myelofibrosis who underwent HCT.
Read MoreSep 9, 2024
Lifetime skin cancer prevalence among sexual minority adults compared with heterosexual adults varied across racial and ethnic groups and sexual orientation.
Read MoreSep 9, 2024
At IFPA 2024, Prof. Adam Reich reviewed itch in psoriasis, while Dr. Anushka Irani discussed the connection between pain and psoriatic disease.
Read MoreSep 9, 2024
During the IFPA 2024, Prof. Philip Mease, MD, from the University of Washington, focused on obesity and fibromyalgia and their impact on psoriatic arthritis.
Read MoreSep 9, 2024
In new advances for psoriasis treatment, topical therapies and creams have shown increased developments for patients.
Read MoreSep 9, 2024
How immune processes influence psoriatic disease development, and how genetic analysis can help predict treatment responses to different therapies.
Read MoreSep 9, 2024
Researchers presented 2024 guidance for diagnosing generalized pustular psoriasis and described differential diagnosis between GPP and other similar conditions.
Read MoreSep 6, 2024
The tricuspid valve percutaneous repair system improved clinical outcomes when compared with guideline-directed medical treatment in patients with severe tricuspid regurgitation.
Read MoreSep 6, 2024
The STOP-or-NOT trial found that both RASI continuation and discontinuation do not appear to affect the outcomes of major non-cardiac surgery.
Read MoreSep 6, 2024
A triple pill protocol was more effective than the standard-of-care BP protocol in lowering BP in Black African patients.
Read MoreSep 6, 2024
Patients with transthyretin amyloidosis with cardiomyopathy had a reduced all-cause mortality and recurrent cardiovascular events with intake of vutrisiran in the HELIOS-B study.
Read MoreSep 6, 2024
Patients with high-risk atrial fibrillation and stable coronary artery disease have better health outcomes with a Edoxaban monotherapy in the EPIC-CAD trial.
Read MoreSep 6, 2024
Finerenone has been shown to significantly reduce the risk for cardiovascular death in patients with heart failure in results from the FINEARTS-HF trial.
Read MoreSep 6, 2024
Researchers found the CFRSD-CRISS score is an effective predictor of lung function recovery after a pulmonary exacerbation in cystic fibrosis.
Read MoreSep 5, 2024
Dr. Jill Bryson explains which medications can be beneficial when incorporated into an obesity treatment plan, and factors that determine medication use.
Read MoreSep 3, 2024
MASLD-related and MetALD-related cirrhosis is responsible for one-third of cirrhosis cases seen in the intensive care unit, according to a recent study.
Read MoreSep 3, 2024
A new classification links MASLD and ALD, based on metabolic dysfunction and alcohol use, with a significant risk of developing chronic kidney disease.
Read MoreSep 3, 2024
A beverage containing collagen peptides (CP), including tripeptides and elastin peptides (EP), is...
Read MoreSep 3, 2024
A recent study demonstrated significant diagnostic discordance and associated mortality for patients with pneumonia hospitalized from the emergency department.
Read MoreSep 3, 2024
Using bidirectional Mendelian randomization, a team of researchers from China found that rheumatoid arthritis had a causal association with bronchiectasis.
Read More